secwatch.observer — SEC 8-K summary
======================================

Issuer:     XBiotech Inc. (XBIT)
CIK:        0001626878
Form:       8-K/A
Filed at:   2025-10-15T23:59:59+00:00
Accession:  0001171843-25-006441
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

XBiotech amends director bio: Rademaker is consultant to multiple PE firms
--------------------------------------------------------------------------

- Clarifies Craig Rademaker is a consultant to several Canadian private equity firms, not a single firm.
- His responsibilities principally include capital markets activities.
- No change to his role as director or any compensatory arrangements.
- Amendment corrects prior 8-K filed June 24, 2025, for Item 5.02.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626878/000117184325006441/0001171843-25-006441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626878/000117184325006441/f8ka_101525.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-006441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer